Characteristics and disease activity of early interstitial lung disease in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung

被引:18
作者
Kashiwabara, K [1 ]
机构
[1] Taragi Municipal Hosp, Resp Dept, Kumamoto 8680501, Japan
关键词
annual health examinations; curvilinear subpleural lines; KL-6; subpleural ground-glass opacities; surfactant protein A; surfactant protein D; thickened interlobular and intralobular lines;
D O I
10.1378/chest.129.2.402
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To evaluate characteristics or disease activity of early interstitial lung disease (ILD) in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung. Patients and methods: This study enrolled 14 subjects with dependent densities that disappeared on helical CT obtained with the subject prone (control group) and 7 subjects with true parenchymal abnormalities that remained unchanged on prone CT image but were not detectable on chest radiographs (true abnormalities group). Pulmonary function tests and serum markers for idiopathic lung fibrosis as KL-6, surfactant protein D (SP-D), and surfactant protein A (SP-A) in the two groups were evaluated. Results: In the true abnormalities group, curvilinear subpleural lines or thickened interlobular and intralobular lines were observed more frequently in the lower lung fields. Diffusing capacities of the lung for carbon monoxide (15.3 +/- 3.5 mL/min/mm Hg vs 18.8 +/- 3.7 mL/min/mm Hg, p = 0.0493) were lower, and KL-6 (607 +/- 297 U/mL vs 318 +/- 143 U/mL, p = 0.0090), SP-A (59 +/- 24 ng/mL vs 34 +/- 12 ng/mL, p = 0.0207), and SP-D (112 +/- 54 ng/mL vs 42 +/- 24 ng/mL, p = 0.0028) were higher in the true abnormalities group than in the control group (+/- SD). Conclusion; True parenchymal abnormalities in the posterior subpleural aspect of the lung may indicate early ILD activity.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 17 条
[1]   ASBESTOS-RELATED PLEURAL AND PARENCHYMAL FIBROSIS - DETECTION WITH HIGH-RESOLUTION CT [J].
ABERLE, DR ;
GAMSU, G ;
RAY, CS ;
FEUERSTEIN, IM .
RADIOLOGY, 1988, 166 (03) :729-734
[2]  
FRASER RS, 1999, FRASER PARES DIAGNOS, P1584
[3]   PULMONARY SURFACTANT PROTEIN-D IN SERA AND BRONCHOALVEOLAR LAVAGE FLUIDS [J].
HONDA, Y ;
KUROKI, Y ;
MATSUURA, E ;
NAGAE, H ;
TAKAHASHI, H ;
AKINO, T ;
ABE, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :1860-1866
[4]   KL-6 - A SERUM MARKER FOR INTERSTITIAL PNEUMONIA [J].
KOBAYASHI, J ;
KITAMURA, S .
CHEST, 1995, 108 (02) :311-315
[5]   Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia [J].
Kohno, N ;
Yokoyama, A ;
Hirasawa, Y ;
Kondo, K ;
Fujino, S ;
Abe, M ;
Hiwada, K .
RESPIRATORY MEDICINE, 1997, 91 (09) :558-561
[6]   NEW SERUM INDICATOR OF INTERSTITIAL PNEUMONITIS ACTIVITY - SIALYLATED CARBOHYDRATE ANTIGEN KL-6 [J].
KOHNO, N ;
KYOIZUMI, S ;
AWAYA, Y ;
FUKUHARA, H ;
YAMAKIDO, M ;
AKIYAMA, M .
CHEST, 1989, 96 (01) :68-73
[7]   KL-6, A MUCIN-LIKE GLYCOPROTEIN, IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH INTERSTITIAL LUNG-DISEASE [J].
KOHNO, N ;
AWAYA, Y ;
OYAMA, T ;
YAMAKIDO, M ;
AKIYAMA, M ;
INOUE, Y ;
YOKOYAMA, A ;
HAMADA, H ;
FUJIOKA, S ;
HIWADA, K .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (03) :637-642
[8]  
KOHNO N, 1988, JPN J CLIN ONCOL, V18, P203
[9]   ELEVATED LEVELS OF LUNG SURFACTANT PROTEIN-A IN SERA FROM PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY ALVEOLAR PROTEINOSIS [J].
KUROKI, Y ;
TSUTAHARA, S ;
SHIJUBO, N ;
TAKAHASHI, H ;
SHIRATORI, M ;
HATTORI, A ;
HONDA, Y ;
ABE, S ;
AKINO, T .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (03) :723-729
[10]   Surfactant protein A and surfactant protein D in health and disease [J].
Mason, RJ ;
Greene, K ;
Voelker, DR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 275 (01) :L1-L13